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Serum amyloid A (SAA) is an apolipoprotein of highdensity lipoprotein (I{DL) particles and is the polymorphic product of a set of genes locatedon the short arm of chromosome ii. SAA is highly conserved in evolution and is a major acute-phase reactant in all species in which it has been studied.Most of the SAA in plasma is synthesized in hepatocytes, under transcriptional regulation by cytokines, especially interleukin-1, interleukin-6, and tumor necrosis factor, acting via nuclear factor ,cB-like (and possibly other) transcription factors (1). After secretion, SAA rapidly associates with HDL, from which it displaces apolipoprotein Al (apoAl The pure SAA was then dialyzed exhaustively against pure water, with low-molecularmass-cutoff benzoylated dialysis tubing (Sigma Chemical Co., Poole, UK), and was stored frozen at -70#{176}C.
Materials and Methods

Acute
Determination of SAA content in acute-phase HDL. Two separate lots of pure SAA in water were exhaustively freeze-dried(Modulyo EF4; Edwards High Vacuum, Crawley, UK) and were kept under reduced pressure until immediately before being weighed (R16OP microgram balance; Sartorius Instruments, Sulton, UK). The masses obtained were 3.55 and 3.29 mg, respectively, with precision of ± 10 pg. These absolute amounts of SAA were dissolved in known volumes of 20 mmol/L Tris-HC1, pH 8.4, and were run in duplicate in reduced SDS/8-18% gradient PAGE (ExcelgeP"; Pharmacia) at loadings ranging from 0.7 to 7 LgIlane. Duplicate dilutions of the acute-phase HDL preparation were run in adjacent and alternating lanes in the same gels.
The gels were then stained with Brilliant Blue R-350, according to the Pharmacia protocol, and 0.5 x 1.0 cm areas of gel, containing only the SAA band, were excised from each lane and extracted for 18 h at room temperature in 1-mL volumes of 250 milL pyridine. Identical sections of the same gels cut from the same region as the SAA band but from lanes in which no protein had been loaded were used as blanks. 
Results
Specificity of anti-SAA
antibodies. The polyclonal rabbit antiserum was monospecific for SAA in agarose gel diffusion immunoprecipitation testing against whole acute-phase serum. It also reacted specifically with AA deposits in immunohistochemical testing. Neither the rabbit nor the mouse monoclonal anti-SAA reagents reacted with normal serum in immunoblots, and they both identified just a single band in acute-phase serum, migrating in the position expected for SAA. They also gave strong positive reactions in immunoblot analysis of pure SAA. Absorption of acute-phase serum with immobilizedrabbit or mouse anti-SAA antibodies resulted in dose-dependent depletion of SAA and was complete if sufficient antibody was used. However, such absorption had no effect on the serum cholesterol concentration, nor was any cholesterol detectable in the eluate from immobilized anti-SAA antibodies that had been incubated in acute-phase serum. The capture process thus involves just SAA and not other components of the HDL particles with which it is associated in serum. This is consistent with the results of preliminary experiments in which we attempted to capture acute-phase HDL for SAA assays by using immobilized antibodies to apoAl and in which no SAA was detectable.
Establishment of the acute-phase serum primwy standard for SAA The SAA content of an acute-phase HDL preparation was determined by the SDS-PAGE method of Godenir et al. (22) . However, we directly measured the absolute mass of SAA used for calibration of the PAGE, in contrast to Godenir et al., who used a colorimetric protein assay based on an albumin standard under the unjustified assumption that SAA behaves identically to albumin in such assays. Extreme precautions were taken to maintain the dried SAA in an anhydrous state, and performance of rapid repeat weighings confirmed that there was no significant mass gain during the brief period between exposure to air and the initial mass determination.
On the basis of the calibrated acute-phase HDL as a standard, 31 separate measurements by RH) assay of the pooled acute-phase serum primary reference material yielded a mean (SD) SAA concentration of 300 (18) mgIL. This value was therefore used in the IMx assays Stability of calibrators, controls, and antibody reagents: Controls containing 56 and 180 mgIL SAA showed no significant change in immunoreactivity when they were subjected to three consecutive cycles of freezing and thawing. Similarly, controls containing 35 and 125 mg/L SAA showed no significant change in immunoreactivity over 3 days at 0, 24, 37, or 45#{176}C. The antibody reagents showed no change in activity after 3 days at 45#{176}C, and after 5 months of storage of all assay materials at 4#{176}C recovery was 92%. Interference: No interference was detected in lipemic, icteric, or hemolyzed sera or samples containing rheumatoid factor. Serum and plasma from the same blood sample gave identical results.
Correlation between RID and IMx assays for SAlt. There was an excellent linearcorrelation between SAA values obtained by the RH) reference method and by the IMx assay (Fig. 1, Table 1 ). The highest values, >300 mg/L, tended to be greater in the IMx than in the reference method, probably because of underestimation by immunodiffusion, but at valuesr <300 mg/L the-two methods gave very similar results.
SAlt concentration in sera of normal subjects. The frequency distribution of SAA values in sera from 105 normal healthy adults overlapped but was higher than that of CRP (Fig. 2) were <5 mgfL and 96% were <10 mg/L. The mean (SD) was 3.7(3.6) mg/L, and the median (range) was 3.0(0.7-26.4) mgfL. SAA concentration in disease. The range of SAA concentrations observed in chronic active inflammatory disease is exemplified by the results in rheumatoid arthritis, shown in Fig. 1 . Similar values were seen in patients with infections, recipients of renal allografts during rejection episodes, postoperative cases, and in unstable angina and after myocardial infarction (submitted for publication).
The highest value observed was 2200 mg/L.
SAA concentration in AA amyloidosis. The concentrations of SAA varied among patients with AA amyloidosis (Fig. 3) , depending on the activity of theirunderlying inflammatory disease. However, it is interesting that the correlation coefficients between SAA and CRP values in these patients ranged from 0.01 to 0.99, with a median of 0.57 and mean (SD) of 0.54 (0.36). Representative examples are shown in Fig. 3 The normal range of SAA in healthy subjects reported here provides a useful reference range. The rare individuals with concentrations >10 mgfL, 5 of 105, were presumably mounting an acute-phase response to some intercurrent subclinical process, and unless they were developing a chronic condition should have lower values if examined a few days or weeks later.
Clinical studies in large groups of patients with a variety of disorders confirmed the rapid production and exceptionally wide dynamic range of the SAA response. AA amyloidosis is of particular interest because of the recent clear evidence that control of the underlying chronic inflammatory process retards progression and can permit regression of the amyloid deposits (15, 31) . Hitherto, only measurements of CRP have been readily available outside research laboratories, but it is the production of SAA, the precursor of AA fibrils, that is critical. We show here that, despite excellent correlation in some cases, CRP concentrations in others do not move in parallel with the SAA response (Fig. 3) , as has previously been reported for many inflammatory conditions (32).
When both CR? and SAA concentrations are only slightly increased, there is little correlation between them (Fig. 3A) . This is not important, but in other situations the discrepancy may be of considerable clinical significance.
For example, SAA may be extremely high and vary greatly while CRP remains rather constant (Fig. 3B) ; however, SAA may not be increased despite persistent increase of CR? (Fig. 3C) , which could lead to inappropriate antiinflammatory therapy if only CRP were being monitored. Finally, there may just be a poor correlation between the behavior of the two proteins (Fig. 3E) , confirming that specific assay of SAA is necessary. The variable relation between the CR? and SAA responses does not seem to be related to the underlying inflammatory disease or to treatment, but further study is required.
